Stada-led €4bn loan spree could push lev pricing wider

The European leveraged finance market is set to contend with loan deals approaching €4bn for the start of September. Over half of that is for the German pharmaceutical firm Stada — a deal that could help make funding more expensive for everyone else, writes Victor Jimenez.

  • By Victor Jimenez
  • 31 Aug 2017

“Every investor is waiting for the Stada loans,” said a leveraged finance banker in London.

Some of the bankers working on Stada, the flashiest and most anticipated deal in the European leveraged loan market for the second ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 19,543.40 76 7.21%
2 BNP Paribas 17,658.36 110 6.52%
3 Goldman Sachs 15,275.80 61 5.64%
4 Deutsche Bank 14,293.34 81 5.27%
5 HSBC 14,165.38 91 5.23%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 6,956.59 58 7.34%
2 Goldman Sachs 6,746.86 54 7.12%
3 Deutsche Bank 5,912.17 58 6.24%
4 Credit Suisse 5,767.09 60 6.09%
5 BNP Paribas 5,158.30 56 5.45%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 33,611.94 263 10.79%
2 Citi 26,772.36 213 8.59%
3 Bank of America Merrill Lynch 25,057.11 221 8.04%
4 Goldman Sachs 23,500.21 166 7.54%
5 Barclays 20,380.66 139 6.54%